A Pilot Study in North Louisiana to Assess the Tolerability of Psilocybin as Well as Its Capacity to Promote Abstinence From Methamphetamine
Phase: EARLY_PHASE1 | Sponsor: Kevin Murnane | Compound: Psilocybin
- Status
- recruiting
- Institution
- Kevin Murnane
- Start date
- 2025-04-04
- End date
- 2027-03-01
- Registry ID
- NCT06899594
Tracked by the DMT Code Clinical Trials Observatory, an open record of DMT-related clinical research.